Tempest awards 22,000 stock options to controller
Tempest Therapeutics, Inc. reported that Corporate Controller Justin Trojanowski received a grant of employee stock options for 22,000 shares of common stock.
Rhea-AI Filing Summary
Tempest Therapeutics, Inc. reported that Corporate Controller Justin Trojanowski received a grant of employee stock options for 22,000 shares of common stock. The options have an exercise price of $1.64 per share and expire on March 30, 2036.
According to the vesting terms, 25% of the options will vest on March 31, 2027, with the remaining options vesting in 36 equal monthly installments thereafter, contingent on his continued service. Following this grant, his reported holdings in these options total 22,000 derivative securities, all held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 22,000 shares
Grant/Award
1 txn
Insider
Trojanowski Justin
Role
Corporate Controller
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 22,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 22,000 contracts (Direct)
Footnotes (1)
- F1. This option shall vest with respect to 25% of the total number of shares underlying the option on March 31, 2027 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service.
Key Figures
Options granted: 22,000 options
Exercise price: $1.64 per share
Expiration date: March 30, 2036
+3 more
6 metrics
Options granted
22,000 options
Employee stock option grant to Corporate Controller
Exercise price
$1.64 per share
Strike price for the 22,000 options
Expiration date
March 30, 2036
Option term end date for the grant
Initial vesting
25% on March 31, 2027
Cliff vest of one-quarter of granted options
Remaining vesting schedule
36 monthly installments
Remaining 75% vests monthly after March 31, 2027
Post-grant derivative holdings
22,000 derivative securities
Total options held directly after the grant
Key Terms
Employee Stock Option, grant/award acquisition, vesting, exercise price, +1 more
5 terms
Employee Stock Option financial
"security_title: "Employee Stock Option (right to buy)""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
grant/award acquisition financial
"transaction_action: "grant/award acquisition""
vesting financial
"This option shall vest with respect to 25% of the total number of shares underlying the option on March 31, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: "1.6400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
derivative securities financial
"total_shares_following_transaction: "22000.0000" for derivative security"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
What did Tempest Therapeutics (TPST) disclose about Justin Trojanowski in this Form 4?
Tempest Therapeutics disclosed that Corporate Controller Justin Trojanowski received a grant of employee stock options for 22,000 shares of common stock, with an exercise price of $1.64 per share and an expiration date of March 30, 2036.
How many Tempest Therapeutics (TPST) options were granted to Justin Trojanowski?
Justin Trojanowski was granted employee stock options covering 22,000 shares of Tempest Therapeutics common stock. These options represent his total reported derivative holdings following the transaction, as shown in this Form 4 filing for the award.
What is the exercise price and expiration date of Justin Trojanowski’s TPST options?
The granted employee stock options have an exercise price of $1.64 per share and expire on March 30, 2036. This means he can buy Tempest Therapeutics common stock at $1.64 per share any time before the expiration date, once the options vest.
How do the Tempest Therapeutics (TPST) options granted to Justin Trojanowski vest?
The options vest over time: 25% of the 22,000 shares vest on March 31, 2027, and the remaining 75% vest in 36 equal monthly installments afterward, subject to Justin Trojanowski’s continued service with Tempest Therapeutics.
Is Justin Trojanowski’s Form 4 transaction a purchase or a compensation grant of TPST options?
The Form 4 shows a compensation-related grant, not an open-market purchase. The transaction uses code “A” for a grant or award acquisition of employee stock options, giving rights to buy 22,000 TPST shares at a fixed $1.64 exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
